La Jolla Pharmaceutical Company, a subsidiary of Innoviva, Inc., is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla markets GIAPREZA® (angiotensin II) injection and XERAVA® (eravacycline) for injection. For more information, please visit www.ljpc.com.
View Top Employees from La Jolla Pharmaceutical CompanyWebsite | https://www.lajollapharmaceutical.com/ |
Ticker | LJPC |
Revenue | $10 million |
Employees | 94 (94 on RocketReach) |
Founded | 1989 |
Address | 201 Jones Rd Suite 400, Waltham, Massachusetts 02451, US |
Phone | (858) 207-4264 |
Fax | (858) 626-2851 |
Technologies |
JavaScript,
HTML,
Twitter
+23 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biopharma, Galectin-3, Healthcare, Biotechnology, Chronic Kidney Disease, Health Care, Hepatorenal Syndrome, Science and Engineering, Therapeutics |
Web Rank | 4 Million |
Keywords | La Jolla Pharmaceutical, La Jolla Pharmaceuticals, Aviara Pharmaceuticals Careers, Lajolla Pharma, Jim Wilkie Biotech |
Competitors | Enzon Pharmaceuticals, Leap Therapeutics, Prexton Therapeutics SA, Puma Biotechnology, Inc., Step Pharma |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 325 Companies |
Looking for a particular La Jolla Pharmaceutical Company employee's phone or email?
The La Jolla Pharmaceutical Company annual revenue was $10 million in 2024.
Luke Seikkula is the Senior Vice President, Pharmaceutical Operations of La Jolla Pharmaceutical Company.
94 people are employed at La Jolla Pharmaceutical Company.
La Jolla Pharmaceutical Company is based in Waltham, Massachusetts.
The NAICS codes for La Jolla Pharmaceutical Company are [3254, 54171, 54, 32, 5417, 541, 541714, 325].
The SIC codes for La Jolla Pharmaceutical Company are [283, 28].